<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01261117</url>
  </required_header>
  <id_info>
    <org_study_id>STO5336205575</org_study_id>
    <nct_id>NCT01261117</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Oral Versus Intravenous Ibuprofen for PDA Treatment in ELBW Infants</brief_title>
  <official_title>Oral Versus Intravenous Ibuprofen Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zekai Tahir Burak Women's Health Research and Education Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zekai Tahir Burak Women's Health Research and Education Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether oral or intravenous ibuprofen has a better or same efficacy and
      tolerance in closure of patent ductus arteriosis in extremely-low-birth-weight preterm
      infants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine whether oral or intravenous ibuprofen has a better or same efficacy and
      tolerance in closure of patent ductus arteriosis in extremely-low-birth-weight preterm
      infants.Seventy ELBW preterm infants with patent ductus arteriosis will be enrolled in this
      prospective-randomized study. Patients will receive either intravenous or oral ibuprofen at
      an initial dose of 10 mg/kg, followed by 5 mg/kg at 24 and 48 h.

      One of the following echocardiographic criteria of a duct size &gt;1.5 mm, a left
      atrium-to-aorta ratio &gt;1.5, left-to-right shunting of blood, end diastolic reversal of blood
      flow in the aorta, or poor cardiac function in addition signs of patent ductus arteriosis
      determined the need of ibuprofen treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy and Safety of Oral Versus Intravenous Ibuprofen... ID: STO5336205575</measure>
    <time_frame>6 months</time_frame>
    <description>To compare the closure rate of patent ductus arteriosus after intravenous or oral ibuprofen treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy and Safety of Oral Versus Intravenous Ibuprofen</measure>
    <time_frame>Results will be identified in 6 months</time_frame>
    <description>Evaluation of renal tolerance and complications</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Patent Ductus Arteriosus</condition>
  <arm_group>
    <arm_group_label>intravenous ibuprofen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Extremely low birth weight patients receiving iv ibuprofen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral ibuprofen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Extremely low birth weight patients receiving oral ibuprofen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oral ibuprofen</intervention_name>
    <description>oral or iv ibuprofen in 10, 5 and 5 mg/kg/day with 24 hr intervals</description>
    <arm_group_label>intravenous ibuprofen</arm_group_label>
    <arm_group_label>Oral ibuprofen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Birth weight below 1000 gram

          -  Diagnosed patent ductus arteriosis by Echocardiographic examination

        Exclusion Criteria:

          -  Accompanied other congenital cardiac anomalies

          -  Severe thrombocytopenia &lt; 60.000

          -  Severe intracranial bleeding (Grade 3-4)

          -  Intestinal abnormality and necrotising enterocolitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omer Erdeve</last_name>
    <role>Study Director</role>
    <affiliation>Zekai Tahir Burak Women's Health Research and Education Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zekai Tahir Burak Maternity Teaching Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06600</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2010</study_first_submitted>
  <study_first_submitted_qc>December 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2010</study_first_posted>
  <last_update_submitted>August 8, 2011</last_update_submitted>
  <last_update_submitted_qc>August 8, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 9, 2011</last_update_posted>
  <responsible_party>
    <name_title>Zekai Tahir Burak Maternity and Teaching Hospital</name_title>
    <organization>Zekai Tahir Burak Maternity and Teaching Hospital</organization>
  </responsible_party>
  <keyword>Patent ductus arteriosis</keyword>
  <keyword>Ä°buprofen</keyword>
  <keyword>Extremely Low Birth Weigh infant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ductus Arteriosus, Patent</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

